Mental and Behavioral Disorders due to... | Code1 |
---|---|
...use of sedatives, hypnotics, anxiolytics | F13 |
...use of cocaine | F14 |
...use of other stimulants, including caffeine | F15 |
...use of hallucinogens | F16 |
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Used for medical claim reporting in all healthcare settings, ICD-10-CM is a standardized classification system of diagnosis codes that represent conditions and diseases, related health problems, abnormal findings, signs and symptoms, injuries, external causes of injuries and diseases, and social circumstances.
Search the full ICD-10 catalog by:
Adverse effect of amphetamines 1 T43.625 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM T43.625 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of T43.625 - other international versions of ICD-10 T43.625 may differ.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes. birth trauma ( P10-P15) obstetric trauma ( O70 - O71)
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code F15.10:
F15.10 is a billable diagnosis code used to specify a medical diagnosis of other stimulant abuse, uncomplicated. The code F15.10 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.